Worsening of myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution
- 1 April 2016
- journal article
- case report
- Published by Elsevier in Neuromuscular Disorders
- Vol. 26 (4-5) , 309-311
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Myasthenia GravisSeminars in Neurology, 2012
- Myasthenic Crisis May Mimic Antipsychotic-Induced Extrapyramidal SyndromesThe Journal of Neuropsychiatry and Clinical Neurosciences, 2011
- A model of anticholinergic activity of atypical antipsychotic medicationsSchizophrenia Research, 2006
- Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National RegistersAmerican Journal of Psychiatry, 2006
- Effects of atypical antipsychotics on vertebrate neuromuscular transmissionNeuropharmacology, 2002
- Myasthenia gravisThe Lancet, 2001
- Editor's MailboxPostgraduate Medicine, 2000
- Drugs and Myasthenia GravisArchives of internal medicine (1960), 1997
- The action of chlorpromazine at an isolated cholinergic synapseBrain Research, 1979
- Chlorpromazine-Induced Weakness in Myasthenia GravisArchives of Neurology, 1963